IRON CLUSTER SEC Filing Analysis

Latest settled — T+20d

IRON ▲ +1.12% at T+20d

SHORT call ✗ call lost -1.12% · α vs SPY +6.60% · entry $68.46 → $69.23

Next anchor: T+60d in 27d

Currently $68.34 · +0.18% from $68.46 entry (call sign-flipped)

Entry anchored
Apr 10, 03:59 PM ET
via Databento tick

T+1d

+2.95%

call -2.95% · α -1.74%

$70.48

settled 8w ago

T+5d

+4.31%

call -4.31% · α -1.01%

$71.41

settled 8w ago

T+20d

+1.12%

call -1.12% · α +6.60%

$69.23

settled 5w ago

T+60d

—

call — · α —

—

in 27d

Price Chart

Loading chart...

Executive Summary

Two C-suite executives at Disc Medicine, Inc. (IRON) sold shares worth $694K in the past week, including CFO Jean M. Franchi and CMO William Jacob Savage. The sales were open-market transactions, representing a coordinated insider sell-off by top leadership.

Key Financial Metrics

Direction

selling

Total Value

$694.3K

Insiders

2

Actionable Insight

Traders should monitor for potential downward pressure on the stock, especially if additional selling follows. The coordinated exit by CFO and CMO raises questions about internal confidence, particularly in a biopharma context where clinical progress is key. Absent positive news, this could signal overvaluation or upcoming risk.

Key Facts

CFO Jean M. Franchi sold 6,657 shares for $460,834 in two transactions on April 13 and 14, 2026.
CMO William Jacob Savage sold 3,531 shares for $233,473 on April 13, 2026.
Total insider sales in the past 7 days amount to $694,307 in open-market transactions.
All transactions were 'S' (open-market sale) codes, indicating deliberate divestment.
Total value represents ~0.026% of the $2.7B market cap — modest in size but significant given concentration among C-suite executives.

Financial Impact

$694K in open-market share sales by two C-suite executives

insider ownershipinvestor sentimentperceived confidence in valuation

Risk Factors

Perception of insider pessimism ahead of clinical data or regulatory decisions
Potential for follow-on selling by other insiders
Increased scrutiny from retail and institutional investors

Market Snapshot

Exchange

Nasdaq

Sector

Pharmaceutical Preparations

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

Document	Accession Number
CLUSTER Data (Synthetic)	cluster-IRON-1776287155695

6 reports for IRON

T+1T+5T+20T+60

Track record builds as more directional reports settle.

Filters

Reports for IRON — sortable, filterable
	Type				Now
Jun 9, 2026 today	Press Release BULLISH ★ 6/10	$66.99 awaiting T+5	awaiting T+5	—	$68.34 (+2.02%)
Jun 1, 2026 8d ago	Press Release NEUTRAL ★ 4/10	$71.97 $67.00	▼ −6.91%	▼ −4.16%	$68.34 (−5.04%)
May 5, 2026 5w ago	8-K NEUTRAL ★ 4/10	$67.59 $69.23	▲ +2.43%	▲ +0.44%	$68.34 (+1.11%)
May 5, 2026 5w ago	Press Release NEUTRAL ★ 5/10	$67.59 $69.23	▲ +2.43%	▲ +0.44%	$68.34 (+1.11%)
Apr 13, 2026 8w ago	Insider Cluster BEARISH ★ 7/10	$68.46 $71.41	▼ −4.31%	▼ −1.01%	$68.34 (+0.18%)
Feb 26, 2026 14w ago	8-K BEARISH ★ 7/10	$67.91 $60.34	▲ +11.15%	▲ +10.02%	$68.34 (−0.63%)

US Market Status

Market Closed — Opens Thu (10h 54m)

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access